Ketohexokinase
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
== Structural highlights == | == Structural highlights == | ||
| - | Human KHK inhibitor interacts with the 2 monomers<ref>PMID:24900346</ref> | + | Human <scene name='48/484861/Cv/3'>KHK inhibitor interacts with the 2 monomers</scene><ref>PMID:24900346</ref>. Water molecule shown as red sphere. |
</StructureSection> | </StructureSection> | ||
==3D structuresm of ketohexokinase== | ==3D structuresm of ketohexokinase== | ||
Revision as of 08:20, 17 April 2016
| |||||||||||
3D structuresm of ketohexokinase
2hlz, 2hqq, 3b3l – hKHK – human
2hw1, 3nbv – hKHK + AMPPNP + fructose
3nbw – hKHK + pyrazole derivative
3nc2, 3nc9, 3nca, 3ro4, 3q92, 3qa2, 3qai – hKHK + inhibitor
References
- ↑ Bais R, James HM, Rofe AM, Conyers RA. The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol. Biochem J. 1985 Aug 15;230(1):53-60. PMID:2996495
- ↑ Asipu A, Hayward BE, O'Reilly J, Bonthron DT. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes. 2003 Sep;52(9):2426-32. PMID:12941785
- ↑ Maryanoff BE, O'Neill JC, McComsey DF, Yabut SC, Luci DK, Jordan AD Jr, Masucci JA, Jones WJ, Abad MC, Gibbs AC, Petrounia I. Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. ACS Med Chem Lett. 2011 Apr 18;2(7):538-43. doi: 10.1021/ml200070g. eCollection, 2011 Jul 14. PMID:24900346 doi:http://dx.doi.org/10.1021/ml200070g
